SHARPIN is a ubiquitin-binding and ubiquitin-like-domaincontaining protein which, when mutated in mice, results in immune system disorders and multi-organ inflammation 1,2 . Here we report that SHARPIN functions as a novel component of the linear ubiquitin chain assembly complex (LUBAC) and that the absence of SHARPIN causes dysregulation of NF-kB and apoptotic signalling pathways, explaining the severe phenotypes displayed by chronic proliferative dermatitis (cpdm) in SHARPIN-deficient mice. Upon binding to the LUBAC subunit HOIP (also known as RNF31), SHARPIN stimulates the formation of linear ubiquitin chains in vitro and in vivo. Coexpression of SHARPIN and HOIP promotes linear ubiquitination of NEMO (also known as IKBKG), an adaptor of the IkB kinases (IKKs) and subsequent activation of NF-kB signalling, whereas SHARPIN deficiency in mice causes an impaired activation of the IKK complex and NF-kB in B cells, macrophages and mouse embryonic fibroblasts (MEFs). This effect is further enhanced upon concurrent downregulation of HOIL-1L (also known as RBCK1), another HOIP-binding component of LUBAC. In addition, SHARPIN deficiency leads to rapid cell death upon tumour-necrosis factor a (TNF-a) stimulation via FADDand caspase-8-dependent pathways. SHARPIN thus activates NFkB and inhibits apoptosis via distinct pathways in vivo.
SHARPIN is a ubiquitin-binding and ubiquitin-like-domaincontaining protein which, when mutated in mice, results in immune system disorders and multi-organ inflammation 1,2 . Here we report that SHARPIN functions as a novel component of the linear ubiquitin chain assembly complex (LUBAC) and that the absence of SHARPIN causes dysregulation of NF-kB and apoptotic signalling pathways, explaining the severe phenotypes displayed by chronic proliferative dermatitis (cpdm) in SHARPIN-deficient mice. Upon binding to the LUBAC subunit HOIP (also known as RNF31), SHARPIN stimulates the formation of linear ubiquitin chains in vitro and in vivo. Coexpression of SHARPIN and HOIP promotes linear ubiquitination of NEMO (also known as IKBKG), an adaptor of the IkB kinases (IKKs) and subsequent activation of NF-kB signalling, whereas SHARPIN deficiency in mice causes an impaired activation of the IKK complex and NF-kB in B cells, macrophages and mouse embryonic fibroblasts (MEFs). This effect is further enhanced upon concurrent downregulation of HOIL-1L (also known as RBCK1), another HOIP-binding component of LUBAC. In addition, SHARPIN deficiency leads to rapid cell death upon tumour-necrosis factor a (TNF-a) stimulation via FADDand caspase-8-dependent pathways. SHARPIN thus activates NFkB and inhibits apoptosis via distinct pathways in vivo.
In addition to the established roles of K63-and K48-linked ubiquitin chains, linear ubiquitin chains have recently emerged as important regulators of the NF-kB pathway, controlling immune responses, as well as cell survival, proliferation, and development [3] [4] [5] [6] [7] [8] . Linear ubiquitin conjugation relies on two RING-between-RING (RBR) domain-containing proteins, HOIL-1L (longer isoform of hemoxidized iron-regulatory protein 2 ubiquitin ligase-1) and HOIP (HOIL-1L interacting protein), which together form the E3 ligase complex LUBAC (linear ubiquitin chain assembly complex) 9 . We became interested in SHARPIN (SHANK-associated RH domaininteracting protein) because of the significant sequence homology of its C-terminal region, enclosing a ubiquitin-like (UBL) domain and a putative ubiquitin-binding NPL4 zinc-finger domain (NZF), with the N-terminal region of HOIL-1L 9, 10 (Fig. 1a) . Initially, we established SHARPIN as a bona fide ubiquitin-binding protein by mapping the ubiquitin binding site to the NZF domain ( Supplementary Fig. 1 ). A direct NZF-dependent interaction of SHARPIN with mono-ubiquitin, linear, and K63 ubiquitin chains was confirmed by pull-down assays ( Supplementary Fig. 1b-d ) and isothermal titration calorimetry (ITC) (Fig. 1b) . Mutagenesis of two key residues surrounding the zinc coordination site of the NZF (T358L, F359V) abolished ubiquitin binding ( Supplementary Fig. 1a, c) . The isolated NZFs of SHARPIN, HOIL-1L and HOIP interact with mono-ubiquitin with similar affinities (Fig. 1b) , recognizing the classical hydrophobic patch surrounding I44, as indicated by the absence of any interaction with mutant I44A ubiquitin (Fig. 1b ) and display no specificity for different chain types ( Fig. 1b and Supplementary Fig. 1c ). These data are consistent with binding assays employing a panel of HOIP and HOIL-1L protein variants expressed in transfected cells or in in vitro ubiquitin binding experiments ( Supplementary Fig. 1e-h ).
We next investigated whether SHARPIN directly associates with the LUBAC complex in cells. Tagged versions of HOIP, HOIL-1L and SHARPIN were readily immunoprecipitated from lysates of transiently transfected HEK293T cells (Fig. 1c) . Likewise, the interaction of endogenous SHARPIN, HOIP and HOIL-1L was confirmed in primary mouse embryonic fibroblasts (MEFs) (Fig. 1d) . The interaction between SHARPIN and HOIP is mediated by the UBL domain of SHARPIN, which recognizes the NZF2 domain of HOIP (Supplementary Fig. 1i, j) . In agreement, the interaction between HOIP and SHARPIN was abolished in response to either deletion or mutation (I272A) of the UBL domain of SHARPIN, but was not affected in the ubiquitin-binding deficient mutant of SHARPIN NZF ( Supplementary  Fig. 2a ). On the other hand, purified HOIL-1L did not interact with fulllength SHARPIN in in vitro binding assays ( Supplementary Fig. 2b ). Thus, HOIP has the capacity to interact with either SHARPIN or HOIL-1L or both of them. Indeed, endogenous HOIP can form a complex with only HOIL-1L or SHARPIN in the absence of the other, because in SHARPIN-or HOIL-1-deficient MEFs, HOIP can coprecipitate with residual HOIL-1L or SHARPIN, respectively (Fig. 1d) . Interestingly, the deficiency of either SHARPIN or HOIL-1L led to a partial destabilization of the other protein (Fig. 1d ). Together these findings indicate the existence of three putative LUBAC complexes: dimeric complexes, HOIP-HOIL-1L (LUBAC-I) and SHARPIN-HOIP (LUBAC-II), and a trimeric SHARPIN-HOIP-HOIL-1L complex ( Supplementary Fig. 2c ).
The purified SHARPIN-HOIP complex stimulated the in vitro assembly of linear ubiquitin chains (Fig. 2a) , similar to the ligase activity of a HOIP-HOIL-1L complex ( Supplementary Fig. 3a ). We thus extended our studies to investigate whether SHARPIN and HOIP can induce linear ubiquitination of proteins in cells. The UBAN domain of ABIN-1 (also known as TNIP1), known to bind linear ubiquitin chains preferentially 11, 12 , was used as an affinity matrix to pull down cellular proteins modified by linear ubiquitination upon overexpression of SHARPIN and HOIP ( Fig. 2b and Supplementary Fig. 3f ). Both the NZF and UBL domains of SHARPIN were essential for this activity, because neither the SHARPIN-NZF (T358L, F359V), nor the SHARPIN-UBL (I272A) mutant showed any ability to induce linear ubiquitination in vivo (Fig. 2b) . Similarly, the ABIN-1-UBAN D485A mutant, which is unable to bind linear polyubiquitin, did not pull down any ubiquitin conjugates ( Fig. 2b and Supplementary Fig. 3d,  e) . A specific enrichment of linear ubiquitination in cells overexpressing SHARPIN and HOIP was further confirmed by tandem mass spectrometry (MS/MS) analysis. In samples transfected with SHARPIN-HOIP as well as HOIP-HOIL-1L the linear ubiquitin peptide GGMQIFVK was detected (Fig. 2c) . MS-based quantification (employing the AQUA approach described in Supplementary Fig. 4a ) detected an increase in the absolute amounts of ubiquitin present in linear chains compared to the total pool of ubiquitin (measured by the TITLEVEPSDTIENVK peptide) in cells expressing wild-type SHARPIN-HOIP, in contrast to cells expressing an inactive SHARPIN-HOIP complex ( Supplementary  Fig. 4b-e) . We next performed a stable isotope labelling using amino acids in cell culture (SILAC)-based quantitative MS/MS analysis on immunoprecipitated NEMO upon co-transfection with either wildtype or inactive SHARPIN-HOIP (experimental design is shown in Supplementary Fig. 5a, b) . The measured intensity of linear ubiquitin peptides on immunoprecipitated NEMO was .25 times higher in cells transfected with wild-type SHARPIN-HOIP compared to cells expressing inactive SHARPIN-HOIP mutants (Fig. 2d, e) . In the same sample we detected 13 ubiquitination sites on NEMO, of which 11 were increased following transfection with wild-type versus mutated SHARPIN-HOIP ( Supplementary Fig. 5c ), indicating that NEMO is a substrate of LUBAC II.
SHARPIN-deficient (Sharpin cpdm/cpdm , abbreviated to cpdm) mice exhibit diverse phenotypes in the immune system, which resemble the phenotypes of genetically engineered mouse models with impaired NF-kB activation 7, 8 . As linear ubiquitination is important for activation of the NF-kB pathway 3, 11, 13, 14 we speculated that the SHARPIN-HOIP LUBAC complex might have a critical role in regulation of the NF-kB pathway. Consistent with this hypothesis, co-transfection of SHARPIN and HOIP increased transcription of a luciferase-based NFkB reporter, similar to the effect of HOIP and HOIL-1L co-expression (Fig. 2f) , whereas no activation of NF-kB was detected when cells were transfected with SHARPIN, HOIL-1L or HOIP alone (Fig. 2f) , or a combination of mutant forms of NZF or UBL domains in SHARPIN together with HOIP ( Fig. 2g) .
Based on the finding that TNF-a stimulated formation of a signalling complex between SHARPIN-HOIP and NEMO ( Supplementary  Fig. 6 ), we reasoned that the SHARPIN-HOIP complex might act as an upstream regulator of IKK activation. In vitro IKK kinase assay showed that TNF-a rapidly enhanced IKK kinase activity in wild-type MEFs, which was delayed and reduced in cells lacking SHARPIN (Fig. 3a) . Upon additional abrogation of HOIL-1L expression in cpdm MEFs by stably expressing short hairpin RNA (shRNA) against HOIL-1L (cpdm shHOIL-1L) IKK activation was further inhibited (Fig. 3a) . Moreover, downstream events of IKK activation, such as phosphorylation and subsequent degradation of IkBa (also known as NFKBIA), as well as nuclear translocation of p65 (also known as RELA), were also reduced in cpdm MEFs and further impaired in response to shRNAmediated downregulation of HOIL-1L ( Given the plethora of evidence presented above that SHARPIN modulates the NF-kB pathway, we further assessed the functional role of SHARPIN in NF-kB activation in vivo using cells isolated from the cpdm mice. The absence of SHARPIN in cpdm splenic B cells stimulated with soluble CD40L (also known as CD40LG) resulted in impaired activation of the NF-kB pathway, evaluated by phosphorylation and degradation of IkBa, compared to wild-type B cells (Fig. 3d) . Similar findings were obtained in thioglycollate-induced peritoneal macrophages from cpdm mice, which in response to bacterial lipopolysaccharide (LPS) stimulation failed to induce an efficient phosphorylation and degradation of IkBa (Fig. 3e ), proper nuclear translocation of the NF-kB transcription factor p65 ( Supplementary Fig. 8a ) or secretion of TNF-a and MCP-1 (Fig. 3f, g ). Furthermore, IL-1b (also known as IL1B) stimulation-induced NF-kB activation was delayed in SHARPINdeficient MEFs ( Supplementary Fig. 8b ). Similarly, we observed partial impairment of JNK activation in response to TNF-a, CD40L or LPS in cpdm MEFs, B cells or macrophages, respectively, compared to wildtype cells ( Fig. 3e and Supplementary Fig. 8c-e) . 
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An interesting feature of cpdm mice is the combination of epidermal hyperplasia and inflammation with the presence of apoptotic bodies in keratinocytes and increased cell death in the skin 15 . Moreover, inhibition of TNF-a-induced NF-kB signalling in keratinocytes results in inflammatory skin lesions as observed in genetically engineered mouse models, as well as in human diseases such as incontinentia pigmenti 7 . Using a highly sensitive impedance-based real-time cell analyser, we found that cpdm MEFs were extremely sensitive to rapid TNF-ainduced cell death (Fig. 4a ). This correlated with an appearance of typical apoptotic cell morphology (Supplementary Fig. 9a ) and early signs (2-4 h after TNF-a stimulation) of apoptotic signalling, including proteolytic cleavage of the initiator caspase, caspase-8, the effector caspase, caspase-3, as well as PARP (also known as PARP1), a substrate of caspase-3 (Fig. 4b) . In agreement with a requirement for caspase activity for the induction of apoptosis, pre-treatment of cpdm cells with the general caspase inhibitor zVAD-FMK abolished the observed cell death in response to TNF-a ( Supplementary Fig. 9b ). When performing the reciprocal experiments on MEFs derived from HOIL-1 null mice 14 , we observed a delayed and significantly weaker induction of the apoptotic response in cells stimulated with TNF-a and cycloheximide (CHX) (Fig. 4a) . In accordance, we were unable to detect rapid activation of caspase-3 and caspase-8 upon TNF-a or TNF-a 1 CHX treatment of HOIL-1L-deficient MEFs (Supplementary Fig. 9c ). Moreover, additional downregulation of HOIL-1L in cpdm MEFs did not further increase TNF-a-induced apoptosis or caspase activation (Supplementary Fig. 9d) , whereas a combined lack of SHARPIN and HOIL-1L had a strong additive effect on the inhibition of the NF-kB pathway RESEARCH LETTER (Fig. 3a-c) . Cell death in cpdm MEFs was not upregulated by other stress stimuli, including staurosporine, brefeldin A and doxorubicin ( Supplementary Fig. 9e-g ).
TNF-a-induced cell death is known to proceed through the cytosolic TNFR1 signalling complex II that is composed of TRADD, TRAF2, RIP1 (also known as RIPK1), caspase-8/10, and the death domain containing protein FADD, which together serve as a cell death checkpoint control in TNF-sensitive cells 16, 17 . The apoptotic cell death displayed by cpdm MEFs occurs through the FADD and caspase-8-containing TNFR1 (also known as TNFRSF1A) complex II, because retroviral transduction of either a dominant negative mutant of FADD or CrmA, a cowpox-virus-derived serine protease inhibitor (serpin) of caspase-8, markedly inhibited TNF-a-induced cell death (Fig. 4c, d) . Importantly, we have also detected activation of caspase-3, -8, and -9 in skin keratinocytes of cpdm mice (Fig. 4e) . Taken together, our results indicate that loss of SHARPIN expression sensitizes cells for TNF-ainduced cell death, in part dependent on a caspase-8 pathway. This phenomenon might be an underlying mechanism for the development of inflammatory skin lesions in cpdm mice.
In conclusion, this study provides physiological evidence for a novel LUBAC complex composed of HOIP, the major catalytic subunit, and the adaptor protein SHARPIN. Together, SHARPIN and HOIP mediate linear ubiquitination of NEMO in vivo (Fig. 2a-e and Supplementary Figs 4 and 5) and activate the NF-kB pathway following overexpression in cells (Fig. 2f, g ). The interaction between multiple ubiquitinated NEMO molecules, via their UBAN domains, may cause conformational changes promoting the activation of IKK kinases 11 . In such a model, the dynamics of NF-kB activation in response to different stimuli may be determined by the distinct ability of NEMO to recognize a variety of ubiquitin signals, including different linkages (linear, K63 and K11) 4, 6, 18 and varying lengths of ubiquitin chains 19 . SHARPIN and HOIL-1L have overlapping roles in the function of LUBAC as a key activator of the IKK complex and NF-kB signalling downstream of several physiological stimuli (Fig. 3) . On the other hand, SHARPIN, but not HOIL-1L, deficiency in mice results in an increased cell death that is dependent on caspase-mediated apoptosis, evident in MEFs and inflammatory skin lesions (Fig. 4) . Given the identified anti-apoptotic function of SHARPIN, this study exposes a putative role for linear ubiquitination in the regulation of cell death and strongly reinforces its impact on NF-kB signalling and immune responses.
METHODS SUMMARY
Protein purification, apoptosis and biochemical assays. Recombinant proteins were expressed in Rosetta cells (Novagen). Detailed descriptions of immunoprecipitation, immunoblotting, glutathione-S-transferase (GST) pull-downs and apoptotic assays are available as Supplementary Information. ITC measurements were performed using a VP-ITC or ITC200 (GE Healthcare), as described in Supplementary Methods. Mice and isolation of primary cells. C57BNL/KaLawRij-Sharpin cpdm /RijSunJ mice (JR7599, The Jackson Laboratory) were raised in a pathogen-free environment. Resting mature B cells were isolated using negative selection by CD43-coated magnetic beads (Miltenyi Biotec), thioglycollate-induced macrophages were harvested from the peritoneal cavity and MEFs were immortalized using SV40 large T-antigen transfection and dilution passaging. Apoptosis assays. Quantitative apoptosis assays were performed in real time using a non-invasive impedance-based real-time cell analyser (Roche).
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature. 
METHODS
cDNA, antibodies and cells. Full-length SHARPIN, NZF (340-387) or UBL (233-314) from HeLa cDNA were subcloned into pGEX-4T1 (GE Healthcare), pEGFP-C1 (Novagen) or pBabe-puro by standard PCR methods. Mutants of SHARPIN T358L, F359V, SHARPIN DNZF (D350-374), SHARPIN I272A, SHARPIN DC (1-232), SHARPIN DUBL, and insertion of 63His-tag in C terminus of pGEX plasmid were introduced by site-directed mutagenesis. pcDNA3-Myc-human HOIP, pcDNA3-HA-human HOIL-1L DRBR-C, pcDNA3-HA-human HOIL-1L DUBL, pcDNA3-HA-human HOIL-1L DNZF, pGEX-6Pp1-HOIP NZF1 (350-379), pGEX-6P-1-HOIP NZF2 (408-438) , and pGEX-6P-1-HOIP NZF112 (350-438) were described previously 14 . pGEX-4T1-Ubiquitin, pGEX-4T1-diUbiquitin, and pGEX-4T1-mouse NEMO-UBAN were described elsewhere 11 . pMALc2x-human NEMO was generated by a standard PCR method. pGEX-4T2-tetra-Ubiquitin was a gift from C. Guo and E. Friedberg. pGEX-4T1-mouse ABIN1-UBAN was described previously 12 . pcDNA3-Myc-human HOIP RING mutant (C699/702S, C871/874S) and pGEX-4T1-mouse ABIN1-UBAN D485A were generated by standard site directed mutagenesis. pMSCV-GFP, pMSCV-Flag-DN-FADD-IRES-GFP, and pMSCV-Flag-CrmA-IRES-GFP were gifts from J. Silke.
Anti-His (Novagen, Madison, WI), anti-Ubiquitin (P4D1; Santa Cruz Biotechnology, Santa Cruz, CA), anti-GFP (B-2; Santa Cruz Biotechnology), anti-HA (HA.11; Covance, Berkeley, CA), anti-Myc (9E10; Santa Cruz Biotechnology), anti-Flag (M2, Covance), anti-Cleaved Caspase 3 (Cell Signaling), anti-Caspase 8 (Cell Signaling), anti-Tubulin (Sigma), anti-Vinculin (Sigma), anti-PARP (Cell Signaling), anti-p65 (Santa Cruz Biotechnology), anti-IkBa (Cell Signaling and Santa Cruz Biotechnology), anti-pIkBa (Cell Signaling), anti-IKKa (Imgenex), anti-NEMO (Santa Cruz Biotechnology), anti-pJNK (Cell Signaling), anti-pp38 (Cell signaling), anti-NUP62 (BD Transduction), anti-GAPDH (Abcam), and anti-Flag M2 agarose (Sigma) were purchased and used according to the manufacturers recommendations. Anti-HOIP and anti-HOIL-1L were described previously 14 . The anti-SHARPIN antibody was raised against a fragment representing the N-terminal region (1-162 amino acids) of human SHARPIN and affinitypurified using the antigen affinity matrix.
Human Embryonic Kidney (HEK) 293T cells (ATCC) were maintained at 37 uC, in 5% CO 2 condition in DMEM (Gibco) supplemented with 10% Fetal calf serum (Gibco) and 100 U/ml penicillin and streptomycin (Invitrogen). Murine TNF-a, IL-1b, and CD40L were purchased from PreproTech, while LPS was from Enzo Life Sciences. zVAD-FMK and cycloheximide were purchased from Bachem and R&D, respectively. SILAC cells. HEK 293T cells were cultured in a custom-made SILAC-DMEM medium (lacking the amino acids lysine and arginine, PAA). The medium was supplemented with dialysed serum (PAA), L-Glutamine, penicillin, streptomycin and amino acids L-lysine and L-arginine. The 'light' culture was supplemented with Lys0 and Arg0 (Sigma); the 'medium-heavy' culture with Lys4 ( All labelled amino acids were purchased from Cambridge Isotope Laboratories. GST protein purification. Transformed Escherichia coli were grown in LB/ampicillin at 37 uC until OD 5 0.3-0.5, induced with 1 mM IPTG and grown over night at 16 uC. The bacteria were harvested by centrifugation and resuspended in GST buffer (20 mM Tris, pH 8.0, 100 mM NaCl) supplemented with complete protease inhibitors (Roche Diagnostics), sonicated, and lysed in 1% Triton X-100. The cleared lysate was incubated with Glutathione Sepharose beads (GE Healthcare) for 2 h at 4 uC with continuous rolling. The beads were subsequently washed with buffer 1 (0.1 M Tris, pH 7.8, 0.5 M NaCl), GST-buffer containing 0.35% Triton X-100 and GST buffer alone. The purified GST-fusions were separated by SDS-PAGE and analysed by Coomassie staining. GST-Pull down and Immunoprecipitation assays. HEK293T cells were transfected with the indicated constructs using FuGene6 (Roche Diagnostics, Mannheim, Germany) or GeneJuice (Novagen) according to the manufacturer's protocol. Cells were treated before lysis (lysis buffer; 50 mM HEPES, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 25 mM NaF, 10 mM ZnCl 2 , 10% glycerol, 1% Triton X-100, supplemented with complete protease inhibitors (Roche)). Cleared lysates were subjected to immunoprecipitation by incubation with the indicated antibodies, followed by Protein A/G Agarose (Santa Cruz Biotechnology) or Protein A-agarose (Roche). Similarly, total cell lysates were incubated with GST-proteins conjugated to Glutathione Sepharose beads at 4 uC. After washing three times with lysis buffer, the immunoprecipitates were separated by SDS-PAGE and analysed by western blot. Purification of proteins for ITC measurements. All constructs for ITC studies have been cloned into pGEX-4T1 or pGEX-6P1 and were expressed using E. coli BL21 as host strain. 5 to 10 l expression culture was grown to an OD of 0.8 in LB/ ampicillin media supplemented with 100 mM ZnCl 2 at 37 uC before induction with 0.1 mM IPTG for 12 h at 25 uC. Cells were resuspended in buffer PX (100 mM HEPES pH 7.4, 500 mM NaCl, 1 mM DTT) and lysed by sonication. The lysate was cleared by centrifugation and loaded onto GSH Sepharose column (GE Healthcare). Bound GST fusion protein was eluted using buffer PX containing 20 mM glutathione, cleaved with thrombin or 3C protease, and further purified by anion exchange chromatography using a Q Sepharose column (GE Healthcare). Fractions containing the protein of interest were polished by size exclusion chromatography on a Superdex 75 or Superdex 200 column (GE Healthcare). Protein concentrations were determined by UV spectrometry at 280 nm using calculated extinction coefficients. K48 and K63-linked ubiquitin chains were prepared essentially as described 20 . Isothermal titration calorimetry. ITC measurements were performed using a VP-ITC or ITC200 (GE Healthcare). Typically 50-100 mM of SHARPIN, HOIL-1L, the isolated NZF domains and the NZF1 of HOIP were loaded into the cell and 500-1,000 mM of ubiquitin or ubiquitin chains into the syringe. Samples were dialyzed into buffer containing 50 mM HEPES pH 7.4, 150 mM NaCl, and 1 mM TCEP. SHARPIN titrations were performed at 10 uC, HOIL-1L, and HOIP titrations at 20 uC. ITC data were analysed with Origin7 (Micro Cal) supplied by the manufacturer. Luciferase assay. HEK293T cells were plated on 48-well plates at a density of 20,000 cells per well 24 h before transfection. pNF-kB-Luc plasmid (Stratagene) and b-GAL plasmid were transfected together with the indicated plasmids using FuGene6. After 36 h of transfection, lysates were prepared and subjected to luciferase assays following the manufacturer's protocol (Roche). Internal control was measured by b-Gal activity using its substrate (Roche). All experiments were done using quadruple samples. In vitro ubiquitination assay. Ubiquitin (10 mg), His-tag E1 (150 ng), UbcH7 (300 ng) (Boston Biochem), and the indicated E3 ligase complexes (1 mg) were incubated with or without 2 mM ATP (Sigma) for the indicated time at 37 uC in ubiquitin assay buffer (20 mM Tris-HCl pH 7.5, 5 mM MgCl 2 , 2 mM DTT). Methylated ubiquitin was used as a negative control. To stop the reaction, SDSloading buffer was added and the samples were boiled at 95 uC for 1 min. The samples were subsequently analysed by SDS-PAGE followed by western blotting using a PVDF membrane. In vitro kinase assay. MEFs of wild-type, cpdm or cpdm HOIL-1L shRNA were treated by TNF-a (20 ng ml
21
) for indicated times. IKK complex was immunoprecipitated by anti-NEMO antibody from the total cell lysates prepared from treated MEFs. Kinase assays were performed using c-( Protein separation, digestion, and mass spectrometry. Complete protein eluates of the three pull-down experiments were combined and separated by 1D SDS PAGE (NuPAGE 12% precast Bis/Tris gels, Invitrogen). The proteins were visualized by staining using the Novex Colloidal Blue Staining Kit (Invitrogen) according to the manufacturer's instructions and the corresponding gel lane was cut into eleven pieces. In gel trypsin digestion of the proteins was performed as described previously 21 . Chloroacetamide was used for alkylation to prevent formation of lysine modifications isobaric to Gly-Gly 22 . Prior to LC-MS peptides were desalted using C 18 StageTips
23
. LC-MS analysis was performed using a Proxeon Easy-LC system (ProxeonBiosystems) coupled to an LTQ-Orbitrap XL mass spectrometer (Thermo Fisher Scientific) equipped with a nano-electrospray ion source (ProxeonBiosystems), as described previously 24 . Peptides were eluted using a segmented gradient of 5-80% of solvent B (80% ACN in 0.5% acetic acid) with a constant flow of 200 nl min 21 over 118 min. Full scan MS spectra were acquired in a mass range from m/z 380 to 920 with a resolution of 60,000 in the Orbitrap mass analyser using the lock mass option for internal calibration 25 . The ten most intense ions were sequentially isolated for CID fragmentation in the linear ion trap. Inclusion list containing 27 ions of special interest (ubiquitinated NEMO and ubiquitin peptides) was used and up to 500 precursor ion masses selected for MS/MS were dynamically excluded for 90 s. Mass spectra were processed and quantified using the MaxQuant software suite 26 (version 1.0.14.3) and the data were searched using Mascot search engine (Matrix Science) against a decoy human database (ipi.HUMAN.v3.64) containing 168,584 protein entries. Carbamidomethylation (Cys) was defined as fixed-, and protein N-terminal acetylation, oxidation (Met), Gly-Gly (Lys), and Gly-Gly (N-terminal) were defined as variable modifications. Initial mass tolerance for the precursor ions was set to 7 p.p.m., and for the fragment ions to 0.5 Da. The Gly-Gly (Lys) modification sites were considered localized if the localization probability (calculated by MaxQuant software) was higher than 0.75. Absolute quantification of ubiquitin in whole cell lysate. For absolute quantification (AQUA 11 ) proteins were precipitated from crude cell lysates of 'light' (SHARPIN/HOIP) and 'medium-heavy' (SHARPIN TF_LV/HOIP RING mutant) SILAC-labelled HEK293T cells by chloroform/methanol precipitation. Protein concentration was measured by Bradford before and after precipitation to RESEARCH LETTER
